Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) 3 (Pyrrolidin 2 yl)pyridine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116286700B reveals enhanced imine reductase mutants for nicotine synthesis offering superior yield and supply chain reliability for global pharmaceutical manufacturers.
Novel biocatalytic route for nicotine intermediate using engineered imine reductase mutants offering superior conversion and stereoselectivity for industrial scale-up.